Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Myelodysplastic Syndromes 16Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Non-Hodgkin 10Lymphoma 9Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia 8Recurrence 6Hodgkin Disease 6Myeloproliferative Disorders 5Lymphoma, Mantle-Cell 5Lymphoma, B-Cell 5Leukemia, Biphenotypic, Acute 5Neoplasms 4Neoplasm, Residual 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Lymphoid 4Immunoproliferative Disorders 4Immune System Diseases 4Burkitt Lymphoma 4Precancerous Conditions 3Lymphoproliferative Disorders 3Lymphoma, B-Cell, Marginal Zone 3Lymphatic Diseases 3Leukemia, Myelomonocytic, Chronic 3

Interventions

Lenalidomide 6carfilzomib 3Dexamethasone 3daratumumab 2Melphalan 2Leflunomide 2poly ICLC 1pembrolizumab 1isatuximab 1fludarabine phosphate 1fludarabine 1citarinostat 1Watchful Waiting 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1PVX-410 vaccine 1Observation 1Myelography 1Metformin 1Cyclophosphamide 1Cholestyramine Resin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Smoldering Multiple Myeloma × fludarabine phosphate × Clear all
NCT05767359 2026-03-12

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
20 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡